All News

Endometriosis has been linked with autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease, but more definitive research is needed

Now that more states are legalizing cannabis for medical and recreational use, pharmacists must step up to educate and counsel customers on safe use

Convatec’s InnovaBurn is the first product of its kind intended to help patients manage burns and wounds.

Your weekly roundup of the latest news from Drug Topics®.

VP-102 hopes to treat molluscum contagiosum, pending approval from FDA

The pharmaceutical giant announced a 70% price reduction for most of its commonly sold insulin.

CMS has no plans to change their coverage and approval process, which the Alzheimer's Association believes is standing between patients and treatment.

Efanesoctocog alfa is a recombinant factor VIII therapy with once-a-week dosing.

The vaccine would be administered to pregnant people to protect newborns from RSV.

Pharmacists generally agree that domestic production of the commonly used antibiotic could prevent more shortages from happening in the future

As inflation rises, consumers are beginning to lose confidence in their ability to cover health care expenses.

Not only were people with newly diagnosed type 2 diabetes less likely to develop dementia if they took pioglitazone, but the benefit was stronger among patients with a history of ischemic heart disease or stroke.

Two studies found digital therapeutics can help patients manage their type 2 diabetes effectively regardless of race or ethnicity.

Collections of oncology drugs in 13 states are being redistributed to patients in need.

Analysts have identifed treatments that may deliver annual sales topping $1 billion over the next 5 years.

The founder of Mark Cuban Cost Plus Drug Company called drug pricing "insane" during a fireside chat at the Association of Accessible Medicines annual meeting.

Anacaulase-bcdb improves current standard of care for deep partial thickness and/or full thickness thermal burns.

At the upcoming hearing, the committee will examine the impact of PBMs on access to healthcare and the Pharmacy Benefit Manager Transparency Act which was submitted by Sens. Maria Cantwell and Chuck Grassley.

After being FDA approved in 2021, tezepelumab (Tezspire) has been approved again for self-administration.

Sacituzumab govitecan significantly improved overall survival over the comparator chemotherapy in patients with hormone receptor–positive, human epidermal growth factor receptor 2–negative breast cancer who had received prior treatment.

Your weekly roundup of the latest news from Drug Topics®.

After an on-field cardiac arrest, Hamlin partnered with the American Heart Association to spotlight the importance of CPR

Geographical data could potentially yield insight on racial and ethnic health disparities in the United States. An analysis of the large dataset could help identify any potential causes for observed inequities.

Adalimumab-atto was first approved by the FDA in 2016.

Sixteen states have banned a pharmacy benefit management practice that involves not counting the value of drug copay assistance from manufacturers toward patient deductibles.

Your weekly roundup of the latest news from Drug Topics®.

Spending on specialty drugs fueled a 11% increase in Medicaid drug spending from 2020 to 2021, says Magellan's seventh annual Medicaid Pharmacy Trend Report.

Your weekly roundup of the latest news from Drug Topics®.